VERAPHARM
ActiveFrom the official registers: KBO 23 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
VERAPHARM has been active since 2002 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €232,349 and a net result of €37,249. Equity has been growing by about 5.4% per year since 2018. Its solvency ranks better than 81% of 22,726 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
History
Acts, filings and financial milestones
20-03
Gazette deed
Resignation: SOETAERT Véronique (director)Reappointment: SOETAERT Véronique (director) · Amendment of the articles · Capital conversion9 points ▸
- General meeting, 09-03-2023
- Amendment of the articles, mentioned 2 times in the deed
- Capital conversion, “statutair onbeschikbare eigen vermogensrekening” (deed in Dutch)
- Reserve release, “opheffing, statutair onbeschikbare eigen vermogensrekening” (deed in Dutch)
- Share issue, 186, “vergoeding voor de inbrengen” (deed in Dutch)
- Director resignation, SOETAERT Véronique (director)
- Director reappointment, SOETAERT Véronique (director (not named in the articles))
- Director discharge, SOETAERT Véronique
- Registered office clause, “1200 Sint-Lambrechts-Woluwe, Paul Hymanslaan 10” (deed in Dutch)
Sources:Publications in the Belgian Official GazetteFilings with the National Bank